Vitamin D Deficiency (Study Outline) For study only—this is…

Vitamin D Deficiency (Study Outline) For study only—this is not medical advice or a substitute for professional care. 1. Background Definition:A condition characterized by inadequate vitamin D levels, resulting in impaired calcium and phosphate absorption, leading to secondary hyperparathyroidism, hypocalcemia, and bone demineralization. Physiology Recap: Vitamin D (cholecalciferol/ergocalciferol) is hydroxylated in the liver → 25-hydroxyvitamin D, then in the kidney → 1,25-dihydroxyvitamin D (calcitriol), the active form. Calcitriol promotes calcium and phosphate absorption in the intestine and reabsorption in the kidney, and stimulates bone mineralization. Pathophysiology: Deficiency → ↓ intestinal calcium absorption → hypocalcemia → compensatory ↑ PTH → secondary hyperparathyroidism. PTH increases bone resorption → osteomalacia (adults) or rickets (children). Causes: Inadequate intake or sunlight exposure (most common). Malabsorption (celiac disease, cystic fibrosis, bariatric surgery). Chronic kidney disease (↓ 1α-hydroxylation). Liver disease (↓ 25-hydroxylation). Medications: anticonvulsants (phenytoin, phenobarbital), glucocorticoids. Exclusive breastfeeding without supplementation in infants. Epidemiology: Common in elderly, limited sun exposure, darker skin pigmentation, and northern latitudes. 2. History Adults (Osteomalacia): Diffuse bone pain and tenderness. Muscle weakness (especially proximal). Fatigue and difficulty walking. Fractures after minimal trauma. Children (Rickets): Delayed growth, bone deformities (bowing of legs, rachitic rosary, frontal bossing). Delayed tooth eruption. Hypotonia and developmental delay (in severe cases). Historical Clues: Minimal sun exposure, low dietary intake, malabsorptive conditions, chronic kidney or liver disease, anticonvulsant use. 3. Exam Findings Adults: Bone tenderness (especially ribs, sternum, long bones). Waddling gait or difficulty rising from chair. Muscle weakness (proximal). Children: Skeletal deformities: Bowed legs (genu varum). Rachitic rosary (costochondral bead-like enlargements). Craniotabes (soft skull). Delayed fontanelle closure. Other: Signs of hypocalcemia in severe cases (Chvostek or Trousseau signs). 4. Making the Diagnosis Laboratory Pattern: Parameter Finding Calcium ↓ or low-normal Phosphate ↓ PTH ↑ (secondary hyperparathyroidism) Alkaline phosphatase ↑ (bone turnover) 25-hydroxyvitamin D (25[OH]D) ↓ (best screening test) Key Diagnostic Points: 25(OH)D < 20 ng/mL = deficiency; 20–30 = insufficiency. 1,25(OH)₂D (calcitriol) is not a good screening test — may be normal or high in early deficiency. X-rays (if bone pain/deformities): Osteopenia, Looser zones (pseudofractures), or bone bowing in children. Bone biopsy (rare): confirms osteoid accumulation (unmineralized bone). Gold Standard: Low 25-hydroxyvitamin D level with corresponding biochemical abnormalities (↑ PTH, ↓ calcium, ↓ phosphate, ↑ ALP). 5. Management (Exam Concepts) (Conceptual overview only—no dosing or treatment regimens.) General Principles: Correct vitamin D deficiency and address calcium intake. Identify and treat underlying causes (malabsorption, CKD, liver disease). Supplementation (Conceptual): Vitamin D2 (ergocalciferol) or D3 (cholecalciferol) replacement. Calcium supplementation to restore balance. Activated vitamin D (calcitriol) in chronic kidney disease (impaired conversion). Lifestyle Measures: Encourage adequate sunlight exposure (10–15 min several times/week). Balanced diet with fortified foods (milk, fish oils, eggs). Monitoring: Recheck calcium, phosphate, ALP, and 25(OH)D levels after therapy. Watch for hypercalcemia during high-dose replacement. NBME-Style Practice Question A 62-year-old woman presents with progressive muscle weakness and diffuse bone pain. She spends most of her time indoors and has a diet low in dairy. Labs show: Calcium: 8.0 mg/dL (low) Phosphate: 2.0 mg/dL (low) Alkaline phosphatase: elevated PTH: elevated 25-hydroxyvitamin D: low Which of the following is the most likely diagnosis? A. Primary hyperparathyroidismB. Osteomalacia due to vitamin D deficiencyC. Paget disease of boneD. Osteoporosis

Hypothyroidism (Study Outline) For study only—this is not me…

Hypothyroidism (Study Outline) For study only—this is not medical advice or a substitute for professional care. 1. Background Definition:A clinical syndrome resulting from deficient production of thyroid hormones (T₄ and T₃) or impaired action at the tissue level. Pathophysiology: Primary hypothyroidism (most common): failure of the thyroid gland → ↑ TSH, ↓ free T₄. Secondary (central): pituitary dysfunction → ↓ TSH and ↓ T₄. Tertiary: hypothalamic failure (↓ TRH). Common Causes (Primary): Autoimmune (Hashimoto thyroiditis) – most common in the U.S. Iatrogenic: post-thyroidectomy, radioactive iodine, or antithyroid medications. Iodine deficiency or excess. Congenital hypothyroidism (thyroid dysgenesis, enzyme defects). Drugs: lithium, amiodarone, interferon-α, tyrosine kinase inhibitors. Epidemiology: More common in women and older adults. Hashimoto’s thyroiditis often associated with other autoimmune disorders (e.g., type 1 DM, pernicious anemia). 2. History Symptoms (Gradual Onset): Fatigue, weakness, cold intolerance. Weight gain despite decreased appetite. Constipation. Dry skin, hair loss, brittle nails. Depression, memory impairment, slowed thinking. Menstrual irregularities, infertility. Severe Forms: Myxedema: severe, long-standing hypothyroidism → nonpitting edema, facial puffiness, hoarseness, periorbital swelling. Myxedema coma: life-threatening decompensation with hypothermia, bradycardia, hypotension, and hypoventilation (precipitated by illness or sedatives). Historical Clues: Prior thyroid surgery or radioactive iodine therapy. Family history of autoimmune disease. Recent medication changes (e.g., lithium, amiodarone). 3. Exam Findings General: Fatigued appearance, weight gain, coarse dry hair, pallor. Skin: Cool, dry, thickened skin; nonpitting edema (myxedema). Cardiovascular: Bradycardia, diastolic hypertension, pericardial effusion (severe). Neurologic: Delayed relaxation of deep tendon reflexes (especially Achilles). HEENT: Puffy face, periorbital edema, enlarged or atrophic thyroid. Other: Macroglossia, hoarseness, carpal tunnel syndrome. Pediatric Findings: Growth retardation, delayed bone age, developmental delay if congenital. 4. Making the Diagnosis Initial Test (Gold Standard): Serum TSH — most sensitive screening test. Interpretation: Primary hypothyroidism: ↑ TSH, ↓ free T₄. Secondary (pituitary): ↓ or inappropriately normal TSH, ↓ free T₄. Subclinical hypothyroidism: mildly ↑ TSH with normal free T₄. Autoimmune Confirmation: Positive anti-thyroid peroxidase (anti-TPO) or anti-thyroglobulin antibodies → Hashimoto thyroiditis. Other Findings: Lipid abnormalities: hypercholesterolemia, ↑ LDL. Hyponatremia: due to decreased free water clearance. Anemia: normocytic or macrocytic. Imaging: Thyroid ultrasound: heterogenous or atrophic gland (Hashimoto). MRI of pituitary: indicated if secondary hypothyroidism suspected. 5. Management (Exam Concepts) (Conceptual overview only—no dosing or treatment directives.) General Principles: Thyroid hormone replacement (e.g., levothyroxine) is standard. Primary hypothyroidism: lifelong replacement and regular TSH monitoring. Secondary hypothyroidism: monitor free T₄, not TSH, for adjustment. Special Situations (Conceptual): Myxedema coma: medical emergency—requires ICU care and supportive management. Pregnancy: increased thyroid hormone requirement; check TSH each trimester. Exam Tip: Drug-induced hypothyroidism → lithium, amiodarone. Most sensitive test: serum TSH. Hashimoto thyroiditis: firm, irregular, painless goiter + positive anti-TPO antibodies. Monitoring: Reassess TSH every 6–8 weeks after dose adjustment. Evaluate for improvement in symptoms, energy, and metabolic parameters.   QUESTION A 45-year-old woman presents with fatigue, weight gain, and constipation. Physical exam shows dry skin, bradycardia, and delayed relaxation of deep tendon reflexes. Laboratory results reveal TSH 9.8 mIU/L (elevated) and free T₄ below normal. Which of the following additional findings is most likely? A. Elevated anti-thyroid peroxidase (anti-TPO) antibodiesB. Elevated free T₃ and suppressed TSHC. Elevated serum calcium and decreased phosphateD. Decreased LDL cholesterol  

Obesity (Study Outline) For study only—this is not medical a…

Obesity (Study Outline) For study only—this is not medical advice or a substitute for professional care. 1. Background Definition:Obesity is a chronic, multifactorial condition characterized by excess adipose tissue leading to metabolic, mechanical, and cardiovascular complications. BMI 25–29.9 = overweight BMI ≥30 = obesity BMI ≥40 = severe obesity (class III) Pathophysiology: Energy imbalance: caloric intake > expenditure. Hormonal factors: Leptin resistance → impaired satiety. Insulin resistance → hyperinsulinemia and weight gain. Ghrelin ↑ → increased appetite. Genetic influences: MC4R mutations (common monogenic cause), polygenic risk. Environmental contributors: sedentary lifestyle, high-calorie diet, stress, sleep deprivation. Adipose tissue as an endocrine organ: Produces inflammatory cytokines → metabolic syndrome. Contributes to dyslipidemia, NAFLD, insulin resistance. Etiology: Behavioral/lifestyle factors High socioeconomic food access to calorie-dense foods Genetic predisposition Secondary causes (exam focus): Hypothyroidism Cushing syndrome Hypothalamic injury Medications: antipsychotics, insulin, sulfonylureas, steroids Epidemiology: Very common in the U.S.; affects all age groups. Strong correlation with cardiometabolic disease. 2. History Weight-related symptoms: Progressive weight gain, difficulty losing weight. Fatigue, joint pain (knees, back). Snoring or daytime somnolence (possible OSA). Metabolic symptoms: Polyuria/polydipsia (possible insulin resistance or T2DM). Dyspnea on exertion. Lifestyle clues: High caloric intake, low physical activity. Stress or sleep disorders affecting appetite regulation. Secondary cause clues: Cold intolerance, constipation (hypothyroidism). Striae, proximal weakness (Cushing syndrome). Hypothalamic injury history. 3. Exam Findings General: Elevated BMI, increased waist circumference (central adiposity). Cardiovascular: Hypertension, tachycardia. Respiratory: Signs of obstructive sleep apnea (large neck circumference). Dermatologic: Acanthosis nigricans (insulin resistance). Intertrigo or skin infections. Musculoskeletal: Joint tenderness, limited mobility. Endocrine clues: Violaceous striae or fat redistribution → possible Cushing syndrome. Thyroid enlargement or bradycardia → possible hypothyroidism. 4. Making the Diagnosis Primary Diagnosis: BMI-based classification on physical exam. Waist circumference: Men >40 in Women >35 in→ associated with ↑ cardiometabolic risk. Screening for Comorbidities (high-yield for exams): Blood pressure: screen for hypertension. Fasting glucose or HbA1c: evaluate for T2DM or insulin resistance. Lipid panel: detect dyslipidemia. Liver function tests: screen for NAFLD. TSH: rule out hypothyroidism. Sleep evaluation: for suspected OSA. Diagnostic Clues: Acanthosis nigricans → insulin resistance. Elevated ALT/AST → fatty liver progression. Gold Standard: Diagnosis is clinical based on BMI, supported by metabolic workup for comorbidities. 5. Management (Exam Concepts) (Conceptual overview only—no dosing or treatment regimens.) 1. Lifestyle Intervention (First-Line) Calorie reduction tailored to nutritional needs. Increased physical activity (aerobic + resistance). Behavioral modification: goal setting, sleep optimization, stress management. 2. Pharmacologic Therapy (Conceptual) Indicated for BMI ≥30 or ≥27 with comorbidities. Mechanisms include appetite suppression, increased satiety, or reduced absorption (no dosing specifics). 3. Bariatric/Metabolic Surgery For BMI ≥40 or ≥35 with comorbidities (T2DM, severe OSA, NAFLD). Produces the largest and most durable weight reduction. Exam clue: resolves or improves T2DM rapidly post-op. 4. Comorbidity Management Treat hypertension, diabetes, dyslipidemia, NAFLD. Screen and treat sleep apnea. Monitor cardiovascular risk factors. Question A 43-year-old woman presents for evaluation of weight gain. She has a BMI of 37 kg/m² and reports daytime fatigue and loud snoring. Physical exam shows a large neck circumference and acanthosis nigricans. Labs reveal elevated fasting insulin and mildly elevated ALT. Which of the following complications is most strongly suggested by these findings? A. HyperthyroidismB. Obstructive sleep apneaC. Addison diseaseD. Primary hyperaldosteronism